Therefore, we set out to map the cleavage sites of these enzymes both to investigate novel mechanisms of Aβ release and also to shed light on the broader cellular processing of APP, potentially opening new avenues for understanding and also treating AD and related conditions. This evidence concerns the gene APP and Alzheimer disease.